(PTX:ASX) Prescient Therapeutics
Live Investor Briefing
Wednesday, August 12th at 7pm AEST
Please join Reach Markets Managing Director Patrick Nelson and Prescient Therapeutics CEO Steven Yatomi-Clarke for a live investor briefing.
Date: Wednesday 12th August
Time: 7pm AEST
- Moving the cancer conversation from “fight” to “cure” with 100% response rates as shown in a recent Johnson & Johnson trial
- PTX’s relationship with the University of Pennsylvania, the minds behind the original CAR-T breakthrough
- PTX’s goal of becoming the “Intel Inside” personalised cancer therapy, and more
- How two of PTX’s assets have been chosen as part of a COVID-19 screen program
These are live and interactive sessions, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.